TY - JOUR
T1 - Cancer vaccines
T2 - Moving toward prevention?
AU - Kwak, Larry W.
PY - 2011/7
Y1 - 2011/7
N2 - After several decades of research, recent successful phase III controlled clinical trials have renewed enthusiasm for vaccine treatment of cancer. This perspective on the report by Berta and colleagues in this issue of the journal (beginning on page 994) discusses the potential prevention of oral cancer through vaccine strategies and, in the broader context, ideal characteristics of tumor antigens as candidates for vaccines for both treating and preventing cancer, potential primary and secondary prevention settings for vaccines, desirable types of immune effectors induced by vaccines, and safety.
AB - After several decades of research, recent successful phase III controlled clinical trials have renewed enthusiasm for vaccine treatment of cancer. This perspective on the report by Berta and colleagues in this issue of the journal (beginning on page 994) discusses the potential prevention of oral cancer through vaccine strategies and, in the broader context, ideal characteristics of tumor antigens as candidates for vaccines for both treating and preventing cancer, potential primary and secondary prevention settings for vaccines, desirable types of immune effectors induced by vaccines, and safety.
UR - http://www.scopus.com/inward/record.url?scp=79960105668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960105668&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-11-0236
DO - 10.1158/1940-6207.CAPR-11-0236
M3 - Short survey
C2 - 21733818
AN - SCOPUS:79960105668
SN - 1940-6207
VL - 4
SP - 954
EP - 956
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 7
ER -